Related Experiment Videos
Negative regulation of T-cell function by PD-1.
Yuan yuan Zha1, Christian Blank, Thomas F Gajewski
1University of Chicago, Department of Pathology, Section of Hematology/Oncology, Chicago, IL 60637, USA.
Critical Reviews in Immunology
|December 14, 2004
Summary
Programmed cell death protein 1 (PD-1) regulates T cell responses. Its ligand, PD-L1, on tumors may enable immune escape, highlighting PD-1 as a target for enhancing antitumor immunity.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Biology
Background:
- Programmed cell death protein 1 (PD-1) is expressed on activated T cells (CD4+ and CD8+).
- PD-1 deficiency in mice leads to autoimmunity, indicating its role in suppressing immune responses.
- PD-1 ligand (PD-L1/B7-H1) expression on tumor cells suggests a mechanism for immune evasion.
Purpose of the Study:
- To review the role of PD-1 and related inhibitory receptors.
- To explore the implications of PD-1 signaling in cancer immunotherapy.
Main Methods:
- Literature review of studies on PD-1, PD-L1, and T cell regulation.
- Analysis of data concerning the expression and function of PD-1 in various biological contexts.
Main Results:
- PD-1 acts as a negative regulator of lymphocyte activation.
- Tumor cells expressing PD-L1 can evade immune surveillance.
- Targeting the PD-1 pathway holds promise for cancer treatment.
Conclusions:
- The PD-1/PD-L1 pathway is a critical checkpoint in immune regulation.
- Modulating PD-1 signaling can overcome tumor-induced immunosuppression.
- Further research into PD-1-based therapies is warranted for effective antitumor immunity.